EVO Human Performance is excited to announce a significant funding milestone, having successfully raised $1,200,000 to advance our mission of redefining the future of sports through our pioneering AI-powered bioengineering solutions. This funding will enable us to enhance our flagship product, artemYs, which utilizes a unique blend of computational fluid mechanics, finite element analysis, and deep learning to deliver highly personalized and actionable insights into athletes' myoskeletal systems. Our cutting-edge technology is already making waves among elite football and basketball clubs competing at the highest levels in European sports and has garnered the trust of high-profile athletes seeking tailored solutions for injury rehabilitation and performance optimization. With this investment, we aim to expand our capabilities in individual performance monitoring and myoskeletal analysis, ultimately setting a new standard in sports technology that prioritizes both peak performance and injury prevention. At EVO Human Performance, we understand the critical role that data-driven insights play in today's competitive sports landscape, facilitating smoother rehabilitation processes and effective recruitment strategies through our comprehensive player profiling reports. This funding infusion not only propels our technological advancements but also ensures that teams, coaches, and athletes have the tools they need to elevate their performance and maintain optimal health. As we embark on this exciting journey, we invite sports professionals to get in touch and discover how EVO Human Performance can enhance their approach to athletic excellence. Together, let’s redefine what’s possible in the realm of sports technology.






